logo

For the Inventor, By the Inventor

Kawasaki, Japan

Kazuo Ohishi

This inventor holds 9 USPTO granted patents and 1 published patent application. Top assignee: Ajinomoto Co., Ltd.. Active years: 1991-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kazuo Ohishi. Retrieved from https://idiyas.com/inventor/kazuo-ohishi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9 

% Patents Active = 66.7

Average Co-Inventor Count = 5.3

ph-index = 5

Forward Citations = 162(Granted Patents)


Location History:

  • Tokyo, JP (1994)
  • Kawasaki, JP (1991 - 2011)

Company Filing History:

goldMedal9 out of 1,953 
 
Ajinomoto Co., Ltd.
 patents

Years Active: 1991-2011

Loading Chart...
9 patents (USPTO):Explore Patents
1. 7973076 - Anti-tumor composition (2011-07-05),
2. 7655696 - Anti-tumor composition (2010-02-02),
3. 6992106 - Anti-tumor composition (2006-01-31),
4. 6462087 - Anti-tumor composition (2002-10-08),
5. 5731353 - Stilbene derivatives and pharmaceutical compositions containing them (1998-03-24),
6. 5674906 - Stilbene compounds and pharmaceutical compositions containing them (1997-10-07),
7. 5525632 - Stilbene derivatives and pharmaceutical compositions containing them (1996-06-11),
8. 5292757 - 1,4-dihydropyridine compounds useful as reverse resistance agents (1994-03-08),
9. 5041579 - Platinum complexes and uses therewith (1991-08-20),

Title: Kazuo Ohishi: Innovator in Anti-Tumor Compositions

Introduction

Kazuo Ohishi is a prominent inventor based in Kawasaki, Japan. He has made significant contributions to the field of cancer treatment through his innovative research and development of anti-tumor compositions. With a total of 9 patents to his name, Ohishi's work is recognized for its efficacy and safety in treating tumors.

Latest Patents

Ohishi's latest patents focus on anti-tumor compositions that utilize a stilbene derivative and a platinum coordination compound. These compositions are designed to be highly efficacious and safe for treating solid or malignant tumors. The methods of cancer and tumor treatment using these compositions are also outlined in his patents, showcasing his commitment to advancing medical science.

Career Highlights

Throughout his career, Kazuo Ohishi has been associated with Ajinomoto Co., Ltd., where he has contributed to groundbreaking research in the field of oncology. His work has not only advanced the understanding of tumor treatment but has also paved the way for new therapeutic options for patients.

Collaborations

Ohishi has collaborated with notable colleagues, including Yoshihiro Morinaga and Yukio Nihei. These partnerships have enhanced the research and development process, leading to innovative solutions in cancer treatment.

Conclusion

Kazuo Ohishi's contributions to the field of anti-tumor compositions highlight his dedication to improving cancer treatment. His innovative patents and collaborations reflect a commitment to advancing medical science for the benefit of patients worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…